UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 238

Sortiert nach

Rational design of a new antibiotic class for drug-resistant infections

Nature (London), 2021-09, Vol.597 (7878), p.698-702

2021

Link zum Volltext

Verfügbarkeit prüfen

Molecular mechanisms of sulbactam antibacterial activity and resistance determinants in Acinetobacter baumannii

Antimicrobial agents and chemotherapy, 2015-03, Vol.59 (3), p.1680-1689

2015

Link zum Volltext

Verfügbarkeit prüfen

Durlobactam, a New Diazabicyclooctane β-Lactamase Inhibitor for the Treatment of Acinetobacter Infections in Combination With Sulbactam

Frontiers in microbiology, 2021-07, Vol.12, p.709974-709974

2021

Link zum Volltext

Verfügbarkeit prüfen

Kinetics of Sulbactam Hydrolysis by β-Lactamases, and Kinetics of β-Lactamase Inhibition by Sulbactam

Antimicrobial agents and chemotherapy, 2017-12, Vol.61 (12)

Shapiro, Adam B

2017

Link zum Volltext

Verfügbarkeit prüfen

Novel Bacterial NAD+-Dependent DNA Ligase Inhibitors with Broad-Spectrum Activity and Antibacterial Efficacy In Vivo

Antimicrobial Agents and Chemotherapy, 2011-03, Vol.55 (3), p.1088-1096

2011

Link zum Volltext

Verfügbarkeit prüfen

A high-throughput, homogeneous, fluorescence resonance energy transfer-based assay for phospho-N-acetylmuramoyl-pentapeptide translocase (MraY)

Journal of biomolecular screening, 2012-06, Vol.17 (5), p.662-672

2012

Link zum Volltext

Verfügbarkeit prüfen

Novel Rapidly Diversifiable Antimicrobial RNA Polymerase Switch Region Inhibitors with Confirmed Mode of Action in Haemophilus influenzae

Journal of Bacteriology, 2012-10, Vol.194 (20), p.5504-5512

2012

Link zum Volltext

Verfügbarkeit prüfen

An aminoquinazoline inhibitor of the essential bacterial cell wall synthetic enzyme GlmU has a unique non-protein-kinase-like binding mode

Biochemical journal, 2012-09, Vol.446 (3), p.405-413

2012

Link zum Volltext

Verfügbarkeit prüfen

Improvement of the Pharmacokinetics and In Vivo Antibacterial Efficacy of a Novel Type IIa Topoisomerase Inhibitor by Formulation in Liposomes

Antimicrobial Agents and Chemotherapy, 2013-10, Vol.57 (10), p.4816-4824

2013

Link zum Volltext

Verfügbarkeit prüfen

Interactions of the Diazabicyclooctane Serine β‑Lactamase Inhibitor ETX1317 with Target Enzymes

ACS infectious diseases, 2021-01, Vol.7 (1), p.114-122

2021

Link zum Volltext

Verfügbarkeit prüfen

A high-throughput-compatible, fluorescence anisotropy-based assay for ATP-dependent supercoiled DNA relaxation by human topoisomerase IIα

Biochemical pharmacology, 2013-05, Vol.85 (9), p.1269-1277

Shapiro, Adam B.

2013

Link zum Volltext

Verfügbarkeit prüfen

Molecular drivers of resistance to sulbactam-durlobactam in contemporary clinical isolates of Acinetobacter baumannii

Antimicrobial agents and chemotherapy, 2023-11, Vol.67 (11), p.e0066523-e0066523

2023

Link zum Volltext

Verfügbarkeit prüfen

Bacterial Cytological Profiling Identifies Rhodanine-Containing PAINS Analogs as Specific Inhibitors of Escherichia coli Thymidylate Kinase In Vivo

Journal of bacteriology, 2021-09, Vol.203 (19), p.e0010521-e0010521

2021

Link zum Volltext

Verfügbarkeit prüfen

Discovery of an Orally Available Diazabicyclooctane Inhibitor (ETX0282) of Class A, C, and D Serine β‑Lactamases

Journal of medicinal chemistry, 2020-11, Vol.63 (21), p.12511-12525

2020

Link zum Volltext

Verfügbarkeit prüfen

Frequency and Mechanism of Spontaneous Resistance to Sulbactam Combined with the Novel β-Lactamase Inhibitor ETX2514 in Clinical Isolates of Acinetobacter baumannii

Antimicrobial agents and chemotherapy, 2018-02, Vol.62 (2)

2018

Link zum Volltext

Verfügbarkeit prüfen

A high-throughput fluorescence anisotropy-based assay for human topoisomerase II β-catalyzed ATP-dependent supercoiled DNA relaxation

Analytical biochemistry, 2014-03, Vol.448, p.23-29

2014

Link zum Volltext

Verfügbarkeit prüfen

Nuclear Targeting with an Auger Electron Emitter Potentiates the Action of a Widely Used Antineoplastic Drug

Bioconjugate chemistry, 2015-12, Vol.26 (12), p.2397-2407

2015

Link zum Volltext

Verfügbarkeit prüfen

Investigation of β-lactam antibacterial drugs, β-lactamases, and penicillin-binding proteins with fluorescence polarization and anisotropy: a review

Methods and applications in fluorescence, 2016-04, Vol.4 (2), p.024002-024002

Shapiro, Adam B

2016

Link zum Volltext

Verfügbarkeit prüfen

Allosteric inhibition of the DNA-dependent ATPase activity of Escherichia coli DNA gyrase by a representative of a novel class of inhibitors

Biochemical pharmacology, 2012-10, Vol.84 (7), p.900-904

2012

Link zum Volltext

Verfügbarkeit prüfen

Fluorescence anisotropy-based measurement of Pseudomonas aeruginosa penicillin-binding protein 2 transpeptidase inhibitor acylation rate constants

Analytical biochemistry, 2014-10, Vol.463, p.15-22

2014

Link zum Volltext

Verfügbarkeit prüfen

Inhibitors of the acetyltransferase domain of N-acetylglucosamine-1-phosphate-uridylyltransferase/glucosamine-1-phosphate-acetyltransferase (GlmU). Part 2: Optimization of physical properties leading to antibacterial aryl sulfonamides

Bioorganic & medicinal chemistry letters, 2012-12, Vol.22 (23), p.7019-7023

2012

Link zum Volltext

Verfügbarkeit prüfen

Reversibility of Covalent, Broad-Spectrum Serine β‑Lactamase Inhibition by the Diazabicyclooctenone ETX2514

ACS infectious diseases, 2017-11, Vol.3 (11), p.833-844

2017

Link zum Volltext

Verfügbarkeit prüfen

NBTI 5463 Is a Novel Bacterial Type II Topoisomerase Inhibitor with Activity against Gram-Negative Bacteria and In Vivo Efficacy

Antimicrobial agents and chemotherapy, 2014-05, Vol.58 (5), p.2657-2664

2014

Link zum Volltext

Verfügbarkeit prüfen

Clinical Outcomes for Patients With Monomicrobial vs Polymicrobial Acinetobacter baumannii-calcoaceticus Complex Infections Treated With Sulbactam-Durlobactam or Colistin: A Subset Analysis From a Phase 3 Clinical Trial

Open forum infectious diseases, 2024-04, Vol.11 (4), p.ofae140-ofae140

2024

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 238

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(199)
Mit Volltextzugriff
(220)

Publikationsform

Sprache

Englisch
(237)
Japanisch
(27)
Spanisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(160)
Life Sciences & Biomedicine
(137)
Humans
(80)
Biochemistry & Molecular Biology
(33)
Animals
(32)
Physical Sciences
(32)
Female
(28)
Male
(28)
Pharmacology & Pharmacy
(26)
Biological And Medical Sciences
(22)
Microbiology
(21)
Adult
(20)
Infectious Diseases
(19)
Middle Aged
(19)
Anti-Bacterial Agents - Pharmacology
(18)
Chemistry
(18)
Kinetics
(17)
Medical Sciences
(16)
Escherichia Coli
(15)
Aged
(14)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Rational design of a new antibiotic class for drug-resistant infections

Molecular mechanisms of sulbactam antibacterial activity and resistance determinants in Acinetobacter baumannii

Durlobactam, a New Diazabicyclooctane β-Lactamase Inhibitor for the Treatment of Acinetobacter Infections in Combination With Sulbactam

Kinetics of Sulbactam Hydrolysis by β-Lactamases, and Kinetics of β-Lactamase Inhibition by Sulbactam

Novel Bacterial NAD+-Dependent DNA Ligase Inhibitors with Broad-Spectrum Activity and Antibacterial Efficacy In Vivo

A high-throughput, homogeneous, fluorescence resonance energy transfer-based assay for phospho-N-acetylmuramoyl-pentapeptide translocase (MraY)

Novel Rapidly Diversifiable Antimicrobial RNA Polymerase Switch Region Inhibitors with Confirmed Mode of Action in Haemophilus influenzae

An aminoquinazoline inhibitor of the essential bacterial cell wall synthetic enzyme GlmU has a unique non-protein-kinase-like binding mode

Improvement of the Pharmacokinetics and In Vivo Antibacterial Efficacy of a Novel Type IIa Topoisomerase Inhibitor by Formulation in Liposomes

Interactions of the Diazabicyclooctane Serine β‑Lactamase Inhibitor ETX1317 with Target Enzymes

A high-throughput-compatible, fluorescence anisotropy-based assay for ATP-dependent supercoiled DNA relaxation by human topoisomerase IIα

Molecular drivers of resistance to sulbactam-durlobactam in contemporary clinical isolates of Acinetobacter baumannii

Bacterial Cytological Profiling Identifies Rhodanine-Containing PAINS Analogs as Specific Inhibitors of Escherichia coli Thymidylate Kinase In Vivo

Discovery of an Orally Available Diazabicyclooctane Inhibitor (ETX0282) of Class A, C, and D Serine β‑Lactamases

Frequency and Mechanism of Spontaneous Resistance to Sulbactam Combined with the Novel β-Lactamase Inhibitor ETX2514 in Clinical Isolates of Acinetobacter baumannii

A high-throughput fluorescence anisotropy-based assay for human topoisomerase II β-catalyzed ATP-dependent supercoiled DNA relaxation

Nuclear Targeting with an Auger Electron Emitter Potentiates the Action of a Widely Used Antineoplastic Drug

ETX2514 is a broad-spectrum β-lactamase inhibitor for the treatment of drug-resistant Gram-negative bacteria including Acinetobacter baumannii

Investigation of β-lactam antibacterial drugs, β-lactamases, and penicillin-binding proteins with fluorescence polarization and anisotropy: a review

Allosteric inhibition of the DNA-dependent ATPase activity of Escherichia coli DNA gyrase by a representative of a novel class of inhibitors

Fluorescence anisotropy-based measurement of Pseudomonas aeruginosa penicillin-binding protein 2 transpeptidase inhibitor acylation rate constants

Inhibitors of the acetyltransferase domain of N-acetylglucosamine-1-phosphate-uridylyltransferase/glucosamine-1-phosphate-acetyltransferase (GlmU). Part 2: Optimization of physical properties leading to antibacterial aryl sulfonamides

Reversibility of Covalent, Broad-Spectrum Serine β‑Lactamase Inhibition by the Diazabicyclooctenone ETX2514

NBTI 5463 Is a Novel Bacterial Type II Topoisomerase Inhibitor with Activity against Gram-Negative Bacteria and In Vivo Efficacy

Clinical Outcomes for Patients With Monomicrobial vs Polymicrobial Acinetobacter baumannii-calcoaceticus Complex Infections Treated With Sulbactam-Durlobactam or Colistin: A Subset Analysis From a Phase 3 Clinical Trial

Suchergebnisse filtern